1. Home
  2. BHVN vs NEU Comparison

BHVN vs NEU Comparison

Compare BHVN & NEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • NEU
  • Stock Information
  • Founded
  • BHVN 2013
  • NEU 1887
  • Country
  • BHVN United States
  • NEU United States
  • Employees
  • BHVN N/A
  • NEU N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • NEU Major Chemicals
  • Sector
  • BHVN Health Care
  • NEU Industrials
  • Exchange
  • BHVN Nasdaq
  • NEU Nasdaq
  • Market Cap
  • BHVN 5.4B
  • NEU 5.1B
  • IPO Year
  • BHVN 2017
  • NEU N/A
  • Fundamental
  • Price
  • BHVN $45.17
  • NEU $535.61
  • Analyst Decision
  • BHVN Strong Buy
  • NEU
  • Analyst Count
  • BHVN 13
  • NEU 0
  • Target Price
  • BHVN $63.42
  • NEU N/A
  • AVG Volume (30 Days)
  • BHVN 729.5K
  • NEU 21.5K
  • Earning Date
  • BHVN 11-12-2024
  • NEU 10-23-2024
  • Dividend Yield
  • BHVN N/A
  • NEU 1.86%
  • EPS Growth
  • BHVN N/A
  • NEU 9.11
  • EPS
  • BHVN N/A
  • NEU 45.05
  • Revenue
  • BHVN N/A
  • NEU $2,775,261,000.00
  • Revenue This Year
  • BHVN N/A
  • NEU N/A
  • Revenue Next Year
  • BHVN $179.00
  • NEU N/A
  • P/E Ratio
  • BHVN N/A
  • NEU $11.95
  • Revenue Growth
  • BHVN N/A
  • NEU 1.37
  • 52 Week Low
  • BHVN $26.80
  • NEU $494.04
  • 52 Week High
  • BHVN $62.21
  • NEU $650.00
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 38.20
  • NEU 46.41
  • Support Level
  • BHVN $43.18
  • NEU $530.20
  • Resistance Level
  • BHVN $54.53
  • NEU $563.96
  • Average True Range (ATR)
  • BHVN 2.57
  • NEU 9.04
  • MACD
  • BHVN -0.85
  • NEU -1.32
  • Stochastic Oscillator
  • BHVN 16.86
  • NEU 33.62

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About NEU NewMarket Corp

NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives. Petroleum additives are used in lubricating oils and fuels to enhance their performance in machinery, vehicles, and other equipment. It comprises two broad product applications. Lubricant additives are formulated chemical solutions that, when blended with base fluids, improve the efficiency, durability, performance, and functionality of mineral oils, synthetic oils, and biodegradable fluids. Fuel additives are chemical components that help oil refiners meet fuel specifications or formulated packages that improve the performance of gasoline, diesel, biofuels, and other fuels.

Share on Social Networks: